Charlie Hospital Semarang Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp2,250 (market cap 183.4T, 1.02B 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 247.2× Charlie Hospital Semarang Tbk.'s market cap, and Chandra Asri Pacific Tbk. is more actively traded (1.02B versus 29.45M). Which is the better fit depends on your goals.
| RSCH | TPIA | |
|---|---|---|
Market Cap | 742B | 183.4T |
Volume | 29.45M | 1.02B |
Lot | 294.49K | 10.23M |
Turnover | 8.14B | 2.24T |
Average Price | 276.35 | 2,188.4 |
Value | 8.14B | 2.24T |
Indicative Equilibrium Price | 270 | 2,250 |
Indicative Equilibrium Volume | 103 | 85.81K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →